US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.280
  • +0.342+36.46%
Close Dec 20 16:00 ET
  • 1.240
  • -0.040-3.13%
Post 19:59 ET
56.27MMarket Cap-0.83P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.900M--
--2024/Q4-- / 3.300M--
--2024/Q32.263M / 3.300M--
--2024/Q22.357M / 30.000M--
--2024/Q10.000 / 10.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.900M--
--2024/Q4-- / 3.300M--
--2024/Q32.263M / 3.300M--
--2024/Q22.357M / 30.000M--
--2024/Q10.000 / 10.000M--

Unlock Free Earnings Estimates

Xilio Therapeutics Earnings Reports

  • Xilio Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 09:28 ET

  • Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

    Nov 7 09:23 ET

  • Xilio Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:54 ET

  • Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

    Aug 8 07:49 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data